BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Ubiquitin protein ligase E3 component n-recognin 4 (UBR4)

January 7, 2016 8:00 AM UTC

Cell culture and mouse studies suggest inhibiting UBR4 could help treat influenza A viral infection. Meta-analysis of eight published RNAi studies and three protein interaction data sets identified UB...